SMART(ER) BIOMANUFACTURING: EVALUATING THE RISKS AND OPPORTUNITIES

September 21, 2023, 11:00 am – 1:30pm ET, Online and Interactive

Advances in manufacturing 4.0 including digitalization, AI, and machine learning offer biopharmaceutical company’s unique opportunities to overhaul antiquated processes to increase productivity, flexibility, and reduced cost. However, as with each great innovation, there are risks, uncertainties, and challenges. Our experts share their individual experiences and insight to help your anticipate challenges and implement better manufacturing strategies to accelerate success.

Meeting Agenda (all times ET and subject to change)

11:00 am – 11:15 am: Welcome + Meet and Greet Networking

11:15 am – 11:40 am: Conversation #1: Connecting Technology, Culture, and Strategy to Support Success

11:40 am – 12:05 pm: Conversation #2: Focusing on the Facility – Structure, Digitalization, Processes

12:05 pm – 12:30 pm: Conversation #3: Harnessing Data and Digital Technologies to Accelerate Manufacturing Efficiencies

12:30 pm – 1:30 pm: Deep Dive Networking

For more details on the program series, please contact:
Brian Caine
Co-Founder and Managing Director
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 908-809-0946
Email: bcaine@healthtech.com

For information regarding sponsorship, please contact:
Companies A-M
Phillip Zakim-Yacouby
Senior Manager, Business Development
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 781-247-1815
Email: pzakim-yacouby@healthtech.com

Companies N-Z
Aimee Croke
Senior Manager, Business Development
Evaluating Biopharma, a Division of Cambridge Healthtech Institute
Phone: (+1) 617-292-0777
Email: acroke@healthtech.com